BioCentury | Jan 4, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2017

...labile proteins to help treat cancer. National University of Singapore Distillery Techniques Melanoma; pancreatic cancer Leukocyte immunoglobulin-like receptor B1...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Cancer

...tumors and preclinical testing to treat hematologic malignancies. TARGET/MARKER/PATHWAY: Major histocompatibility complex class I (MHCI); leukocyte immunoglobulin-like receptor B1...
...of Medicine, Stanford, Calif. email: irv@stanford.edu CONTACT: Roy Maute, same affiliation as above email: rmaute@stanford.edu Jennie Walters CD47 Leukocyte immunoglobulin-like receptor B1...
BioCentury | Nov 29, 2017
Preclinical News

Researchers identify second macrophage inhibitory pathway as target for cancer immunotherapy

...researchers at Stanford University and colleagues found blocking major histocompatibility complex class I (MHCI) or leukocyte immunoglobulin-like receptor B1...
Items per page:
1 - 3 of 3